Form 4: Treace Medical Concepts CFO Sells Shares to Cover Tax Obligations

Mark Hair, CFO of Treace Medical Concepts, disposed of 8,594 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Mark Hair, the Chief Financial Officer of Treace Medical Concepts, Inc., filed a Form 4 indicating a transaction involving the company's common stock.
• On January 10, 2025, Mr. Hair disposed of 8,594 shares of common stock.
• The disposal was a result of tax obligations related to the vesting of restricted stock units.
• Following the transaction, Mr. Hair directly owns 359,321 shares of common stock, which includes 326,548 restricted stock units.
• He also indirectly owns 1,200 shares through dependents.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider transaction. It does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend or issue within the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical executive stock transactions.
• Similar filings are regularly seen across the medical device industry, with executives often selling shares to cover tax obligations related to stock awards.
• Companies like Stryker (SYK) and Zimmer Biomet (ZBH) also have executives who regularly file Form 4s for similar transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive to cover tax obligations.

Key Dates

Keywords

Form 4, Treace Medical Concepts, TMCI, Mark Hair, CFO, stock disposal, restricted stock units, insider trading